World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
52
Citations
9428
World Ranking
16715
National Ranking
6903

Overview

Frederick S. Buckner is affiliated with the University of Washington in the United States. Their research primarily spans the field of Medicine, with a strong focus on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Organic Chemistry, and Molecular Biology.

The scientist's work covers numerous topics, including:

  • Trypanosoma species research and implications
  • Research on Leishmaniasis Studies
  • Synthesis and Biological Evaluation
  • COVID-19 Clinical Research Studies
  • Parasitic Infections and Diagnostics
  • RNA and protein synthesis mechanisms
  • Biochemical and Molecular Research

Frederick S. Buckner has contributed to research on clinical and infectious disease issues, with notable papers such as:

  • Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington (2020), published in Clinical Infectious Diseases
  • Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection (2020), published in Clinical and Translational Science
  • Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection (2021), published in Antimicrobial Agents and Chemotherapy
  • Synthesis and Structure−Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases (2020), published in ChemMedChem
  • Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei (2020), published in RSC Medicinal Chemistry

Frederick S. Buckner frequently publishes in the following venues:

  • Antimicrobial Agents and Chemotherapy
  • ChemMedChem
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Clinical and Translational Science

The scientist often collaborates with co-authors including:

  • J. Robert Gillespie
  • Aisha Mushtaq
  • Ranae M. Ranade
  • Zhongsheng Zhang
  • Erkang Fan

Best Publications

  • Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.

    F S Buckner;C L Verlinde;A C La Flamme;W C Van Voorhis

  • Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness

    Shilpi Khare;Advait S. Nagle;Agnes Biggart;Yin H. Lai

  • Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

    Advait S. Nagle;Shilpi Khare;Arun Babu Kumar;Frantisek Supek

  • Genomic-scale prioritization of drug targets: the TDR Targets database

    Fernán Agüero;Bissan Al-Lazikani;Martin Aslett;Matthew Berriman

  • Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in Mice

    Ramesh Gujjar;Alka Marwaha;Farah El Mazouni;John White

  • Heterologous expression of proteins from Plasmodium falciparum: Results from 1000 genes

    Christopher Mehlin;Erica Boni;Frederick S Buckner;Linnea Engel

  • Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

    Laxman Nallan;Kevin D. Bauer;Pravin Bendale;Kasey Rivas

  • Lead-optimization of aryl and aralkyl amine based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice

    Ramesh Gujjar;Farah El Mazouni;Karen L. White;John White

  • Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.

    Kayode K Ojo;Eric T Larson;Katelyn R Keyloun;Lisa J Castaneda

  • Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics

    Michael H. Gelb;Wesley C. Van Voorhis;Frederick S. Buckner;Kohei Yokoyama

  • Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS.

    Frederick S. Buckner;Claire Pomeroy

  • Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease

    James M. Kraus;Christophe L. M. J. Verlinde;Mandana Karimi;Galina I. Lepesheva

  • Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase

    A. M. Aronov;S. Suresh;F. S. Buckner;W. C. Van Voorhis

  • Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation.

    Richard T. Eastman;Frederick S. Buckner;Kohei Yokoyama;Michael H. Gelb

  • Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.

    Jerome C. Bressi;Christophe L. M. J. Verlinde;Alex M. Aronov;My Le Shaw

  • Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery.

    James M. Kraus;Hari Babu Tatipaka;Sarah A. McGuffin;Naveen Kumar Chennamaneni

  • Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.

    Jerome C. Bressi;Jungwoo Choe;Melinda T. Hough;Frederick S. Buckner

  • Recent Developments in Sterol 14-demethylase Inhibitors for Chagas Disease.

    Frederick S. Buckner;Julio A. Urbina

  • Hypertension following erythropoietin therapy in anemic hemodialysis patients.

    Buckner Fs;Eschbach Jw;Haley Nr;Davidson Rc

  • Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington.

    Frederick S Buckner;Denise J McCulloch;Vidya Atluri;Michela Blain

Frequent Co-Authors

Wesley C. Van Voorhis
Wesley C. Van Voorhis University of Washington
Christophe L. M. J. Verlinde
Christophe L. M. J. Verlinde University of Washington
Michael H. Gelb
Michael H. Gelb University of Washington
Wim G. J. Hol
Wim G. J. Hol University of Washington
Ethan A. Merritt
Ethan A. Merritt University of Washington
Andrew D. Hamilton
Andrew D. Hamilton New York University
Said M. Sebti
Said M. Sebti Virginia Commonwealth University
Peter J. Myler
Peter J. Myler Seattle Children's Hospital
Kenneth Stuart
Kenneth Stuart University of Washington
John H. White
John H. White McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to diverse online degrees and flexible career pathways. Many students expand their qualifications with specialized programs tailored for the medical and healthcare industries.

For those eyeing advanced nursing roles, earning a cheapest post master's fnp program can be a smart and cost-effective route. Nurses with an associate degree may quickly upskill by choosing one of the rn to bsn pathways to boost their credentials.

Nutrition is another thriving field branching from biochemistry. If you're passionate about health and wellness, consider earning an online nutrition degree. Additionally, ambitious professionals can move into leadership roles by pursuing an online masters in healthcare management.

These related online programs provide flexible learning options, affordable tuition, and accelerated pathways for both traditional students and working professionals.

Best Scientists Citing Frederick S. Buckner

Trending Scientists

Recently Published Articles